English  |  正體中文  |  简体中文  |  Items with full text/Total items : 1657/1756
Visitors : 3812583      Online Users : 155
RC Version 5.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Adv. Search
LoginUploadHelpAboutAdminister

Please use this identifier to cite or link to this item: http://140.112.115.32:8080/ir/handle/987654321/2772

Title: Hinokitiol is a novel glycoprotein VI antagonist on human platelets
Authors: Wan-Jung Lu;Ming-Ping Wu;Kuan-Hung Lin;Yu-Chen Lin;Hsiu-Chu Chou;Joen-Rong Sheu
Contributors: 視光學系
Keywords: Collagen receptors;convulxin;glycoprotein VI;hinokitiol;platelet activation
Date: 2014-01-01
Issue Date: 2025-08-01 15:07:02 (UTC+8)
Abstract: Hinokitiol (4-isopropyl-tropolone) is a bioactive compound with various pharmacological activities that is found in the wood of cupressaceous plants. Platelet activation plays an important role in thrombogenesis. In our previous study, hinokitiol specifically inhibited collagen-induced platelet aggregation ex vivo and prolonged thrombogenesis in vivo. The glycoprotein (GP) VI and integrin α2?1 are major collagen receptors that mediate platelet adhesion and aggregation. In our current study, we investigated which of these collagen receptors is involved in the hinokitiol-mediated inhibition of platelet activation. Treatment with 2?100?µM hinokitiol caused a dose-dependent right, parallel shift in the collagen concentration?response curve (0.5?10?µg/ml), with no change in the maximal responses. Furthermore, hinokitiol inhibited platelet aggregation and relative [Ca2+]i mobilization stimulated by convulxin, an agonist of GP VI, but not by aggretin, an agonist of integrin α2?1, indicating that hinokitiol mediates the inhibition of platelet activation through GP VI, rather than through integrin α2?1. Hinokitiol also specifically inhibited the convulxin-mediated activation of protein kinase C, phospholipase C?2, Akt, mitogen-activated protein kinases, and Lyn. Hinokitiol markedly diminished the co-immunoprecipitation of GP VI-bound Lyn after convulxin stimulation. In conclusion, hinokitiol, an antagonist of collagen GP VI may represent a novel antiplatelet drug for the prevention of thrombi associated with coronary and cerebral artery diseases.
Relation: Platelets, 25(8), 595-602. https://doi.org/10.3109/09537104.2013.863856
Appears in Collections:[視光學系] 期刊論文

Files in This Item:

File SizeFormat
index.html0KbHTML9View/Open


All items in MMUIR are protected by copyright, with all rights reserved.

 


DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback